As of Oct 02
| +0.04 / +1.42%|
The 4 analysts offering 12-month price forecasts for Oncothyreon Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a +75.44% increase from the last price of 2.85.
The current consensus among 5 polled investment analysts is to Buy stock in Oncothyreon Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.